0001140361-21-035381.txt : 20211026
0001140361-21-035381.hdr.sgml : 20211026
20211026070047
ACCESSION NUMBER: 0001140361-21-035381
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211025
FILED AS OF DATE: 20211026
DATE AS OF CHANGE: 20211026
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossman Jerrold B
CENTRAL INDEX KEY: 0001542519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36728
FILM NUMBER: 211345895
MAIL ADDRESS:
STREET 1: 65 COMMERCE WAY
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADMA BIOLOGICS, INC.
CENTRAL INDEX KEY: 0001368514
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 562590442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O ADMA BIOLOGICS, INC.
STREET 2: 465 STATE ROUTE 17
CITY: RAMSEY
STATE: NJ
ZIP: 07446
BUSINESS PHONE: (201) 478-5552
MAIL ADDRESS:
STREET 1: C/O ADMA BIOLOGICS, INC.
STREET 2: 465 STATE ROUTE 17
CITY: RAMSEY
STATE: NJ
ZIP: 07446
FORMER COMPANY:
FORMER CONFORMED NAME: R&R ACQUISITION VI, INC
DATE OF NAME CHANGE: 20060707
4
1
form4.xml
FORM 4
X0306
4
2021-10-25
0001368514
ADMA BIOLOGICS, INC.
ADMA
0001542519
Grossman Jerrold B
C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
RAMSEY
NJ
07446
true
Common Stock
2021-10-25
4
P
0
100000
1
A
260864
D
Common Stock
22857
I
See Footnote
Common Stock
31381
I
See Footnote
Common Stock
38294
I
See Footnote
Common Stock
175
I
See Footnote
Represents a purchase from the underwriters in the October 2021 public offering of the issuer.
These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
These shares are owned by the reporting person's wife.
/s/ Dr. Jerrold B. Grossman, by Brian Lenz as Attorney-in-fact
2021-10-25